Monsanto wheat patent disputed

Greenpeace, Indian groups challenge company's rights to strain known as Nap Hal

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Greenpeace is challenging patent rights to a wheat strain granted to Monsanto, the world's largest genetically modified (GM) seed company, on grounds of “biopiracy.” The dispute continues the environmental group's demands against patenting of any plants, animals, humans, and genes.

Greenpeace says the patented variety of wheat possesses genetic characteristics originally derived from a strain known as Nap Hal used to make chapatis, the flat bread traditional to northern India.

“Monsanto is trying to get ownership of the specific genetic traits of Nap Hal,” Greenpeace Genetic Engineering Campaigner Christoph Then told The Scientist. “It's robbery of generations of effort in cultivation of Indian farmers.”

The company vigorously denied the allegations. “The people opposing the patent allege there's nothing novel here. But it is indeed a novel invention,” Monsanto Europe–Africa's Director of Public Affairs Thomas McDermott said. “The patent has been granted, and we will defend it.”

Nap Hal has less ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Charles Choi

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo